Forgot your password?

Forgot your username?

Global Database of Emerging Companies

A powerful research and due diligence tool for investors, entrepreneurs, and business development executives.

The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.

Searched:             1 - 30 of 22282 results       < Prev | Next >

Wound Management Technologies Inc

Fort Worth, TX, USA | Provides collagen based wound care technology.
keywords: Wound care, regenerative medicine, woundcare Fort Worth TX USA Robert Lutz, CEO; Cathy Bradshaw, President of Wound Care Innovations, LLC Division; Barry E. Constantine, Project Consultant, Quality Manager

Opexa Therapeutics

The Woodlands, TX, USA | Develops treatments for autoimmune diseases.
keywords: Regenerative medicine, immunotherapy, multiple sclerosis, secondary progressive multiple sclerosis, inflammatory disease, MS The Woodlands TX USA Neil Warma, President and Chief Executive Officer; Jaye Thompson, Ph.D., Senior-Vice President of Clinical Development and Regulatory Affairs; Don Healy Ph.D., Vice-President of Scientific Development and Manufacturing; Donna R. Rill, Senior Vice-President of Operations; John Ginzler

OncoSec Medical

San Diego, CA, USA | Developing novel, localized anti-cancer therapies to avert side-effects
keywords: Oncology, metastatic cancer, melanoma, metastasis, chemotherapy, immunotherapy, dermatology, DrugDelivery, San Diego CA USA Punit Dhillon, President and CEO; Caryn Peterson, Vice President

Biovista, Inc.

Charlottesville, United States | Repurposing drugs for unmet clinical needs.
keywords: ocular, opthalmology, diabetes, obesity, CNS, oncology Charlottesville VA United States Andreas Persidis Ph.D., CEO, Co-Founder; Aris Persidis Ph.D, President, Co-Founder; Graham Anthony, MBA

C3 International, Inc.

Garden Grove, CA, USA | The first all natural medical marijuana pill.
keywords: Cannabinoid Therapeutic, Nutriceutical, Specialty Pharmaceutical, Pain Management Garden Grove CA USA Steele Smith, President and CEO.

NanoViricides, Inc.

West Haven, CT, USA | Anti-viral drugs to fight HIV, influenza, and other infections
keywords: anti-viral drugs, HIVAIDS, dengue, influenza, herpes, adenovirus, keratitis, Immunology, DrugDelivery West Haven CT USA Eugene Seymour, MD, MPH

Amarantus BioScience

Sunnyvale, CA, USA | Biotechnology company that develops modifying treatments to address cell death.
keywords: Parkinsons Disease, PD, CNS, cell death, biotechnology, apoptosis, neurodegenerative diseases, cardiovascular diseases, cardiovascular, neurodegenerative, Parkinsons disease

Bacterin International

Belgrade, MT, USA | Bone graft material and anti-infective coatings for medical applications
keywords: wound, woundcare, orthopedic, medical device, skin, dermal, cartilage, grafts, tissue, regeneration, stem cells

Molly Mason, Investor Relations, Bacterin International Belgrade MT

Belgrade, MT, USA |
keywords: Molly Mason

Martin Cleary, Chairman & CEO, Amarantus BioScience Sunnyvale CA

Sunnyvale, CA, USA |
keywords: Martin Cleary

Gerald Commissiong, , Amarantus BioScience Sunnyvale CA

Sunnyvale, CA, USA |
keywords: Gerald Commissiong

Aris Persidis, President, Biovista, Inc. Charlottesville VA

Charlottesville, United States |
keywords: Aris Persidis

Graham Anthony, , Biovista, Inc. Charlottesville VA

Charlottesville, United States |
keywords: Graham Anthony

Guy Cook, CEO , Chairman of the Board, President and Chief Scientific Officer, Bacterin International Belgrade MT

Belgrade, MT, USA |
keywords: Guy Cook

Eugene Seymour, , NanoViricides, Inc. West Haven CT

West Haven, CT, USA |
keywords: Eugene Seymour

Deborah Hutchinson, President, Wound Management Technologies Inc Fort Worth TX

Fort Worth, TX, USA |
keywords: Deborah Hutchinson

Susie Benson, Director, Human Resources, Bacterin International Belgrade MT

Belgrade, MT, USA |
keywords: Susie Benson

Yvonne Zappulla, IR for Bacterin, Bacterin International Belgrade MT

Belgrade, MT, USA |
keywords: Yvonne Zappulla

James Tong, Chief Financial Officer, Tianyin Pharmaceutical (TPI) Chengdu

Chengdu, China | Short Version:James Jiayuan Tong MD, PhD. is CFO, CBDO and Board Director of Tianyin Pharmaceuticals (NYSE Amex: TPI), headquartered at Chengdu, China. Prior to joining Tianyin in 2010, Dr. Tong was the Head of China Healthcare Investment Banking at ROTH Capital and before that a biotechnology analyst at Rodman & Renshaw. Prior to his Wall Street career, he was Principal Investigator at Marine Biological Laboratory at Woods Hole, MA and a Senior Research Fellow at University of California, Irvine. Dr. Tong was awarded Ph.D. in Neurobiology and Behavior from Cold Spring Harbor Laboratory / Stony Brook University Neuroscience program where he developed an innovative method to significantly extend life spans of animals based on his work on mitochondria, aging and learning disorders in Neurofibromatosis-1 (NF1) disease. He published three first-authored Nature articles and currently holds two patents. Dr. Tong received his medical degree from Peking University Health Science Center. Long version. Dr. James Jiayuan Tong Dr. Tong joined Tianyin as Chief Financial Officer and Chief Business & Development Officer, and a member of the Company's Board of Directors on April 1, 2010. Prior to his position at Tianyin, Dr. Tong was the Head of China Healthcare Investment Banking at ROTH Capital Partners, Newport Beach, CA. He initially joined ROTH as an equity research analyst, spearheading ROTH's effort in China healthcare universe, covering a series of U.S.-listed Chinese pharmaceutical, biotech, medical devices and drug retail businesses. Prior to that, Dr. Tong was a biotechnology analyst at Rodman & Renshaw, New York, covering biotech entities focusing on molecular diagnostics and cures for Alzheimer's disease, multiple sclerosis and cancer. Before his Wall Street career, Dr. Tong was Principal Investigator at Marine Biological Laboratory (MBL) sponsored by Grass Foundation at Woods Hole, MA and a Senior Research Fellow at University of California, Irvine (UCI). Dr. Tong was awarded Ph.D. in Neurobiology and Behavior from Cold Spring Harbor Laboratory / Stony Brook University Neuroscience program. He developed an innovative method to significantly extend life spans of animals based on his work on mitochondria, aging and learning disorders in Neurofibromatosis-1 (NF1) disease. He published three first-authored Nature articles and currently holds two patents. Dr. Tong received his medical degree from Peking University Health Science Center.
keywords: James Tong

Edward Bayham, Vice President of Sales, Marketing, and Business Development, ISTO Technologies St. Louis MO

St. Louis, MO, USA |
keywords: Edward Bayham

Mitchell Seyedin, President and CEO, ISTO Technologies St. Louis MO

St. Louis, MO, USA |
keywords: Mitchell Seyedin

Scott Gill, Chief Financial Officer, ISTO Technologies St. Louis MO

St. Louis, MO, USA |
keywords: Scott Gill

Robert Kloecker, Marketing Director, ISTO Technologies St. Louis MO

St. Louis, MO, USA |
keywords: Robert Kloecker

Nicholas Virca, CEO, Mast Therapeutics, Inc. San Diego CA

San Diego, United States |
keywords: Nicholas Virca

Ioana Hone, Investor Relations, Mast Therapeutics, Inc. San Diego CA

San Diego, United States |
keywords: Ioana Hone

Gordon Sangster, CFO, A.P. Pharma Redwood City CA

Redwood City, CA, USA |
keywords: Gordon Sangster

Lorie Calvo, Media contact, Northwest Biotherapeutics Bethesda MD

Bethesda, MD, USA |
keywords: Lorie Calvo

Stephen Thompson, Vice President and CFO, Access Pharmaceuticals Dallas TX

Dallas, TX, USA |
keywords: Stephen Thompson

James Thomasch, Chief Financial Officer, PLC Medical Systems Inc. Milford MA

Milford, MA, USA |
keywords: James Thomasch

John DeBernardis, COO, Applied NeuroSolutions Vernon Hills IL

Vernon Hills, IL, USA |
keywords: John DeBernardis

Searched:             1 - 30 of 22282 results       < Prev | Next >